Breast pathology
Pathology
G
Sample Data
| Front | Molecular or Biological Classification |
| Back | - ER-PR positive, HER- negative (also termed "luminal," 50% to 65% of cancers):• HER2-positive (approximately 20% of cancers)• ER-PR negative, HER2-negative tumors ( triple negative carcinoma), approximately 15% of cancers) ( |
| Tags |
| Front | Proliferative Breast Disease Without Atypia: |
| Back | associated with a small increase in the risk of subsequent carcinoma in either breast (predictor of Ca.) • Epithelial hyperplasia. The lumen is filled by a heterogeneous, mixed population of luminal and myoepithelial cell types
 |
| Tags |
| Front | Benign epithelial lesions:Non proliferative breast changes (fibrocystic changes) |
| Back | It is not associated with an increased risk of breast cancer:principle changes include:1. Cystic change, often with apocrine metaplasia2. fibrosis,:3. Adenosis:4. fibrocystic changes: grossly showed cysts. Microscopically sowed cystic changes, apocrine metaplasia and stromal fibrosis
 |
| Tags |